Molecular Analysis, Pathogenic Mechanisms, and Readthrough Therapy on a Large Cohort of Kabuki Syndrome Patients
暂无分享,去创建一个
G. Scarano | A. Ferlini | B. Mandriani | G. Merla | L. Micale | C. Fusco | B. Augello | M. Neri | L. Garavelli | L. Boccone | L. Salviati | L. Zelante | S. Sotgiu | C. Maffeo | A. Selicorni | F. Zucchetti | P. De Nittis | M. T. Pellico | R. Fischetto | M. Silengo | E. Biamino | Chiara Perrìa | G. Serra | E. Lapi | M. L. Cavaliere | P. Chiurazzi | M. D. Monica | F. Faravelli | P. Ferrari | L. Mazzanti | A. Pilotta | M. Patricelli | M. Bedeschi | F. Benedicenti | P. Prontera | B. Toschi | D. Melis | E. Di Battista | A. Vancini | M. Pellico
[1] Y. Fukushima,et al. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. , 1981, The Journal of pediatrics.
[2] Y. Kuroki,et al. A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. , 1981, The Journal of pediatrics.
[3] S. Knudsen,et al. Prediction of human mRNA donor and acceptor sites from the DNA sequence. , 1991, Journal of molecular biology.
[4] David Haussler,et al. Improved splice site detection in Genie , 1997, RECOMB '97.
[5] S Rozen,et al. Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.
[6] Stuart L. Schreiber,et al. Active genes are tri-methylated at K4 of histone H3 , 2002, Nature.
[7] J. Rousset,et al. Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment , 2004, Gene Therapy.
[8] Xing Zhang,et al. The SET-domain protein superfamily: protein lysine methyltransferases , 2005, Genome Biology.
[9] S. Morishita,et al. Cloning and expression of a brain-specific putative UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase gene. , 2005, Biological & pharmaceutical bulletin.
[10] C. Croce,et al. Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and Growth , 2006, Molecular and Cellular Biology.
[11] K. Korach,et al. Estrogen receptors and human disease. , 2006, The Journal of clinical investigation.
[12] A. Zharkikh,et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral , 2005, Journal of Medical Genetics.
[13] T. Veenstra,et al. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases , 2007, Proceedings of the National Academy of Sciences.
[14] S. Grellscheid,et al. Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy , 2008, Human Genetics.
[15] Howard Y. Chang,et al. A histone H3 lysine 27 demethylase regulates animal posterior development , 2007, Nature.
[16] J. Rousset,et al. In vitroprediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study , 2007 .
[17] Christophe Béroud,et al. UMD‐predictor, a new prediction tool for nucleotide substitution pathogenicity—application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2 , 2009, Human mutation.
[18] S. Henikoff,et al. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.
[19] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[20] Alexandre Reymond,et al. An atypical 7q11.23 deletion in a normal IQ Williams–Beuren syndrome patient , 2010, European Journal of Human Genetics.
[21] Emily H Turner,et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome , 2010, Nature Genetics.
[22] S. Mandal,et al. Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing , 2010, The FEBS journal.
[23] A. Shilatifard,et al. Histone H3 lysine 4 (H3K4) methylation in development and differentiation. , 2010, Developmental biology.
[24] A. Munnich,et al. In vitro readthrough of termination codons by gentamycin in the Stüve–Wiedemann Syndrome , 2010, European Journal of Human Genetics.
[25] J. Shendure,et al. Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome , 2011, American journal of medical genetics. Part A.
[26] A. Reymond,et al. Mutation spectrum of MLL2 in a cohort of kabuki syndrome patients , 2011, Orphanet journal of rare diseases.
[27] H. Smeets,et al. MLL2 mutation spectrum in 45 patients with Kabuki syndrome , 2011, Human mutation.
[28] S. Mandal,et al. HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment. , 2011, Journal of molecular biology.
[29] J. Rousset,et al. Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides , 2010, Nucleic acids research.
[30] D. Wieczorek,et al. A mutation screen in patients with Kabuki syndrome , 2011, Human Genetics.
[31] Manuel A. S. Santos,et al. Cancer syndromes and therapy by stop-codon readthrough. , 2012, Trends in molecular medicine.
[32] J. Dougherty,et al. Pharmaceutical therapies to recode nonsense mutations in inherited diseases. , 2012, Pharmacology & therapeutics.
[33] J. Miller,et al. Predicting the Functional Effect of Amino Acid Substitutions and Indels , 2012, PloS one.
[34] G. Pesole,et al. TRIM8 modulates p53 activity to dictate cell cycle arrest , 2012, Cell cycle.
[35] Min Gyu Lee,et al. Trans-tail regulation of MLL4-catalyzed H3K4 methylation by H4R3 symmetric dimethylation is mediated by a tandem PHD of MLL4. , 2012, Genes & development.
[36] Siulan Vendramini-Pittoli,et al. Analysis of MLL2 gene in the first Brazilian family with Kabuki syndrome , 2012, American journal of medical genetics. Part A.
[37] M. Digilio,et al. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. , 2012, American journal of human genetics.
[38] Jae W. Lee,et al. UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to activate the cardiac developmental program. , 2012, Developmental cell.
[39] W. Reardon,et al. How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum , 2011, European Journal of Human Genetics.
[40] G. Merla,et al. Absence of deletion and duplication of MLL2 and KDM6A genes in a large cohort of patients with Kabuki syndrome. , 2012, Molecular genetics and metabolism.
[41] J. Rousset,et al. Statistical Analysis of Readthrough Levels for Nonsense Mutations in Mammalian Cells Reveals a Major Determinant of Response to Gentamicin , 2012, PLoS genetics.
[42] T. Morio,et al. Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia‐telangiectasia , 2012, Human mutation.
[43] M. Esteller,et al. Genetic syndromes caused by mutations in epigenetic genes , 2013, Human Genetics.
[44] G. Merla,et al. Report of the First Clinical Case of a Moroccan Kabuki Patient with a Novel MLL2 Mutation , 2013, Molecular Syndromology.
[45] J. Tolmie,et al. MLL2 mosaic mutations and intragenic deletion–duplications in patients with Kabuki syndrome , 2013, Clinical genetics.
[46] N. Niikawa,et al. KDM6A Point Mutations Cause Kabuki Syndrome , 2013, Human mutation.
[47] B. Wollnik,et al. Unmasking Kabuki syndrome , 2013, Clinical genetics.
[48] A. Hoischen,et al. MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype–phenotype study , 2013, Clinical genetics.
[49] J. Rosenfeld,et al. Haploinsufficiency of KDM6A is associated with severe psychomotor retardation, global growth restriction, seizures and cleft palate , 2013, Human Genetics.
[50] N. Niikawa,et al. MLL2 and KDM6A mutations in patients with Kabuki syndrome , 2013, American journal of medical genetics. Part A.
[51] A. Zannettino,et al. EZH2 and KDM6A Act as an Epigenetic Switch to Regulate Mesenchymal Stem Cell Lineage Specification , 2014, Stem cells.
[52] B. Grisart,et al. Novel KDM6A (UTX) mutations and a clinical and molecular review of the X‐linked Kabuki syndrome (KS2) , 2015, Clinical genetics.